Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Piperidine-derived resensitizers revive aminoglycoside capacity against persister cells of Pseudomonas aeruginosa in vivo
AuthorsYeseul Kim; Minju Kim; Haneun Lee; Areum Park; Su Yong Shim; Yura Lee; Kyungjin Lee; Soohyun Lee; Do Young Jin; Jun-Seob Kim; Dongeun Yong; Won-Gon Kim; Choong-Min Ryu; Hyuk Lee; Hwi Won Seo; Jaesung Kwak; Dajeong Kim
AffiliationsInfectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea; Department of Functional Genomics, KRIBB School, University of Science and Technology (UST), Daejeon 34113, Republic of Korea; Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea; Department of Chemistry, Yonsei University, Seoul 03722, Republic of Korea; Department of Chemistry, Hanyang University, Seoul 04763, Republic of Korea; Division of Medicinal Chemistry and Pharmacology, KRICT School, UST, Daejeon 34113, Republic of Korea; Department of Biosystems and Bioengineering, KRIBB School, UST, Daejeon 34113, Republic of Korea; Department of Nano-Bioengineering, Incheon University, Incheon 22012, Republic of Korea; Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
Tumor-intrinsic PHGDH inhibition sensitizes colorectal cancer to PD-1 blockade via α-ketoglutarate–mediated macrophage reprogramming
AuthorsJieping Qiu; Jingwen Wei; Jiaming Liu; Jing Bai; Keqin Tan; Yuhao Wei; Haorui Zhou; Lusi Feng; Qianlong Kang; Huan Tong; Yuting Jiang; Yu Zhang; Jiaqing Yang; Xiaoqian Yang; Qin Zhang; Jingsi Dong; Yuwen Zhou; Xuelei Ma
AffiliationsDepartment of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Postgraduate students, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Colorectal Cancer Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China
ITPKB suppresses ER calcium release to promote CXCL9 expression and enhance immunotherapy sensitivity in triple-negative breast cancer
AuthorsKejing Zhang; Xia Wang; Qiaoli Yi; Huajie Guan; Jiayu Wang; Fengyu Tan; Zhiyang Zhou; Xudong Zhu; Cheng Zhan; Jin Wang; Jianmin Wu; Hailin Tang; Zhijie Xu; Zeyu Shuang; Yuanliang Yan
AffiliationsDepartment of Pharmacy, National Clinical Research Center for Geriatric Diseases (Xiangya Hospital of Central South University), The Hunan Institute of Pharmacy Practice and Clinical Research, Xiangya Hospital, Central South University, Changsha 410008, China; Department of General Surgery, Xiangya Hospital, Central South University, Changsha 410008, China; Department of Pathology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou 510060, China; Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA; Department of Thoracic Surgery, Cancer Center, Zhongshan Hospital, Fudan University, Shanghai 200032, China
Targeting a novel metabolic vulnerability of non-small cell lung cancer to fatty acid oxidation surmounts chemoresistance
AuthorsSimona Fontana; Dimas Carolina Belisario; Claudia Giannotta; Luca Alessandri; Sabrina Digiovanni; Angelo Meoli; Francesco Passiglia; Alessandra Merlini; Giulianmichela Di Palma; Martina Perin; Francesca Napoli; Maddalena Arigoni; Muhlis Akman; Elisa Balmas; Costanzo Costamagna; Iris Chiara Salaroglio; Joanna Kopecka; Alessandro Bertero; Luisella Righi; Massimo Massaia; Raffaele Calogero; Silvia Novello; Giorgio Vittorio Scagliotti; Yehuda G. Assaraf; Chiara Riganti
AffiliationsDepartment of Oncology, University of Torino, Torino, Italy; Molecular Biotechnology Center “Guido Tarone”, University of Torino, Torino, Italy; Candiolo Cancer Institute, Fondazione del Piemonte per l’Oncologia-IRCCS, Candiolo, Italy; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy; Medical Oncology Unit, Department of Oncology at AOU San Luigi Hospital, Orbassano, Italy; Pathology Unit, Department of Oncology at AOU San Luigi Hospital, Orbassano, Italy; Neuroscience Unit, Bahcesehir University, Istanbul, Turkey; Division of Hematology, AO Santa Croce e Carle, Cuneo, Italy; The Fred Wyszkowski Cancer Research Laboratory, Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel
MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer
AuthorsWang Liu; Lily He; Cuncong Zhong; Yuzhuo Wang; Da Zhang; Moben Mirza; Benyi Li
AffiliationsDepartments of Urology, The University of Kansas Medical Center, Kansas City, KS 66160, USA; Departments of Pathology & Laboratory Medicine, The University of Kansas Medical Center, Kansas City, KS 66160, USA; Department of Electrical Engineering & Computer Science, The University of Kansas School of Engineering, Lawrence, KS 66045, USA; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver V5Z 1M9, Canada
ZBED6-driven nucleotide metabolic reprogramming improves sensitivity to anti-PD1 therapy in NK/T cell lymphoma
AuthorsCailu Song; Wenjian Liu; Xiaofang Xie; Cheng Peng; Lewei Zhu; Lingrui Liu; Yutian Zou; Xiaoming Xie; Hailin Tang; Jia Zhu; Chengcheng Liu; Hua Wang
AffiliationsState Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China; Chinese Medicine Germplasm Resources Innovation and Effective Uses Key Laboratory of Sichuan Province, State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China; The First People's Hospital of Foshan (Foshan Hospital Affiliated to Southern University of Science and Technology), School of Medicine, Southern University of Science and Technology, Foshan, Guangdong, China; Department of Hematology, The Third Affiliated Hospital of Sun Yat-Sen University; Institute of Hematology, Sun Yat-sen University, Guangzhou , Guangdong , China
Protein SUMOylation confers sorafenib resistance in human hepatocellular carcinoma via the induction of PKM2-mediated glycolysis
AuthorsHongchao Yuan; Yuanjun Lu; Zhuofeng Jiang; Yau-Tuen Chan; Junyu Wu; Zixin Feng; Lin Xu; Qiucheng Li; Pengde Lu; Chun-Fung Kwok; Tung-Leong Fong; Qinguo Huang; Liuya Wei; Yibin Feng; Zhe-Sheng Chen; Ning Wang
AffiliationsSchool of Chinese Medicine, LKS Faculty of Medicine, The University of Hong Kong, 3 Sassoon Road, Pokfulam, Hong Kong; Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China; Laboratory for Synthetic Chemistry and Chemical Biology Limited, Hong Kong Science Park, Hong Kong; Department of Neurosurgery, The Second Affiliated Hospital, Shantou University Medical College, Shantou, China; School of Pharmacy, Shandong Second Medical University, Weifang, Shandong, China; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, USA; Department of Chinese Medicine, the University of Hong Kong–Shenzhen Hospital (HKU-SZH), Shenzhen, China
ZDHHC16-induced GPX2 S-palmitoylation promotes lenvatinib resistance and inhibits lenvatinib-induced immunogenic cell death in hepatocellular carcinoma
AuthorsLong He; Guangquan Zhang; Yuxiu Sun; Xinli Liu; Yuanming Song; Ziyue Zhang; Tiantian Fu; Tianhe Zhang; Xinlei Wang; Yang Li; Hongwei Yang; Wen Liu; Ningning Liu; Zhe Wang
AffiliationsDepartment of Organ Transplantation, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China; Organ Transplant Center, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, China; Department of Hepatobiliary and Pancreatic Surgery, The Eighth Affiliated Hospital of Sun Yat-sen University, Biological Laboratory of Hetao Cooperation Zone, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong 518033, China; Department of Digestive Diseases 1, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China; Department of Digestive Diseases 3, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China; Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China; Dalian Medical University, Dalian, Liaoning 116044, China; Department of Thoracic Radiation Oncology Ward I, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning 110042, China; Department of Neurosurgery, The People’s Hospital of China Medical University, The People’s Hospital of Liaoning Province, Shenyang, Liaoning 110016, China; Department of Interventional Therapy, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China; Department of Plastic Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China; Department of Radiology, Jinshan Hospital, Fudan University, Shanghai 201508, China; Department of Ophthalmology, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China
Fluorinated multi-mechanism antimicrobial peptides for improved potency against multidrug-resistant bacterial infections
AuthorsLuyang Gao; Chao Zhong; Qiqi Yu; Jingyi Zhu; Wenjing Xue; Jing Zou; Jiahui Wang; Ning Xu; Sanhu Gou; Yun Zhang; Hui Liu; Jingman Ni
AffiliationsInstitute of Pharmaceutics, School of Pharmacy, Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, and Research Unit of Peptide Science, Chinese Academy of Medical Sciences, Lanzhou University, Lanzhou, China; State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao, China; State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, China
A multifunctional antimicrobial peptide with cell-penetrating and β-lactam-potentiating activities for combating methicillin-resistant Staphylococcus aureus and carbapenem-resistant Enterobacteriaceae infections
AuthorsXiaoxiao Zhang; Yuxin Zhang; Xiaoxue Zhang; Wenshuai Li; Yixin Hou; Yao Wang; Lei Xu; Xihui Shen
AffiliationsShaanxi Key Laboratory of Agricultural and Environmental Microbiology, College of Life Sciences, Northwest A&F University, Yangling, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
